BIO vs. CLSK

Last updated Apr 1, 2026

Compare and contrast key facts about Bio-Rad Laboratories, Inc. (BIO) and CleanSpark, Inc. (CLSK).

Performance

BIO vs. CLSK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bio-Rad Laboratories, Inc. (BIO) and CleanSpark, Inc. (CLSK). The values are adjusted to include any dividend payments, if applicable.

BIO vs. CLSK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BIO Bio-Rad Laboratories, Inc.	-8.00%	-7.77%	1.74%	-23.21%	-44.35%	29.61%	57.54%	59.34%	-2.70%	30.94%
CLSK CleanSpark, Inc.	-15.91%	9.88%	-16.50%	440.69%	-78.57%	-67.23%	442.99%	-73.90%	-15.98%	-30.29%

Fundamentals

EPS BIO : $28.09 CLSK : -$1.28
PS Ratio BIO : 2.92 CLSK : 2.20
Total Revenue (TTM) BIO : $2.58B CLSK : $785.19M
Gross Profit (TTM) BIO : $1.34B CLSK : $256.57M
EBITDA (TTM) BIO : $288.60M CLSK : $131.94M

Returns By Period

In the year-to-date period, BIO achieves a -8.00% return, which is significantly higher than CLSK's -15.91% return. Over the past 10 years, BIO has outperformed CLSK with an annualized return of 7.17%, while CLSK has yielded a comparatively lower -11.84% annualized return.

BIO

• 1D: 3.10%
• 1M: 0.11%
• YTD: -8.00%
• 6M: -0.58%
• 1Y: 14.45%
• 3Y*: -16.51%
• 5Y*: -13.63%
• 10Y*: 7.17%

CLSK

• 1D: 4.03%
• 1M: -14.47%
• YTD: -15.91%
• 6M: -41.31%
• 1Y: 26.64%
• 3Y*: 45.20%
• 5Y*: -18.02%
• 10Y*: -11.84%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BIO vs. CLSK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIO

BIO Risk / Return Rank: 54
BIO Sharpe Ratio Rank: 55
BIO Sortino Ratio Rank: 52
BIO Omega Ratio Rank: 50
BIO Calmar Ratio Rank: 56
BIO Martin Ratio Rank: 57

CLSK

CLSK Risk / Return Rank: 53
CLSK Sharpe Ratio Rank: 53
CLSK Sortino Ratio Rank: 59
CLSK Omega Ratio Rank: 55
CLSK Calmar Ratio Rank: 50
CLSK Martin Ratio Rank: 49

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIO vs. CLSK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and CleanSpark, Inc. (CLSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BIO	CLSK	Difference
Sharpe ratio Return per unit of total volatility	0.34	0.29	+0.04
Sortino ratio Return per unit of downside risk	0.84	1.11	-0.27
Omega ratio Gain probability vs. loss probability	1.11	1.12	-0.02
Calmar ratio Return relative to maximum drawdown	0.60	0.28	+0.32
Martin ratio Return relative to average drawdown	1.47	0.54	+0.93
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BIO vs. CLSK - Sharpe Ratio Comparison

The current BIO Sharpe Ratio is 0.34, which is comparable to the CLSK Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of BIO and CLSK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BIO	CLSK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.34	0.29	+0.04
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.38	-0.18	-0.20
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.22	-0.06	+0.28
Sharpe Ratio (All Time) Calculated using the full available price history	0.26	-0.06	+0.33

Correlation

The correlation between BIO and CLSK is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BIO vs. CLSK - Dividend Comparison

Neither BIO nor CLSK has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

BIO vs. CLSK - Drawdown Comparison

The maximum BIO drawdown since its inception was -83.64%, smaller than the maximum CLSK drawdown of -98.56%. Use the drawdown chart below to compare losses from any high point for BIO and CLSK.

Drawdown Indicators

	BIO	CLSK	Difference
Max Drawdown Largest peak-to-trough decline	-83.64%	-98.56%	+14.92%
Max Drawdown (1Y) Largest decline over 1 year	-24.49%	-64.74%	+40.25%
Max Drawdown (5Y) Largest decline over 5 years	-73.77%	-92.25%	+18.48%
Max Drawdown (10Y) Largest decline over 10 years	-73.77%	-98.56%	+24.79%
Current Drawdown Current decline from peak	-66.24%	-88.34%	+22.10%
Average Drawdown Average peak-to-trough decline	-27.58%	-69.27%	+41.69%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.04%	33.98%	-23.94%

Volatility

BIO vs. CLSK - Volatility Comparison

The current volatility for Bio-Rad Laboratories, Inc. (BIO) is 9.14%, while CleanSpark, Inc. (CLSK) has a volatility of 22.06%. This indicates that BIO experiences smaller price fluctuations and is considered to be less risky than CLSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BIO	CLSK	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.14%	22.06%	-12.92%
Volatility (6M) Calculated over the trailing 6-month period	25.84%	70.97%	-45.13%
Volatility (1Y) Calculated over the trailing 1-year period	42.95%	91.62%	-48.67%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	36.31%	101.41%	-65.10%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.45%	184.30%	-150.85%

Financials